Peptide CMC manufacturing
Yifan Biopharma is focused on providing comprehensive peptide solutions to biopharmaceutical companies and research institutions worldwide. Our industry-leading technology platform provides our customers with full cycle peptide services from early stage development to commercial production.
• Chemical Development
This includes the design and optimization of the synthesis route of peptides, the selection of appropriate synthesis methods and protection strategies to ensure high yield and high purity peptide synthesis. Chemical development also involves the confirmation of the structure of peptides and the development of purification methods.
• Manufacturing Process
This involves the development and optimization of the production process of peptide drugs, which means of the production process, selection and procurement of raw materials, optimization of process parameters, as well as scale-up of production batches and process validation.
• Quality Control
This is a critical step in ensuring the quality of peptide drugs. Quality control includes the evaluation of the physical properties, chemical properties and biological activity of peptide drugs, as well as the establishment of appropriate quality standards and analytical methods. Quality control also includes the study and control of the stability of peptide drugs.
In Peptide CMC development, it is necessary to follow relevant regulations and guidelines, such as the requirements of the Food and Drug Administration (FDA) and related pharmacopoeias. These requirements cover quality standards for peptide drugs, validation and control of the manufacturing process, as well as stability assessment of drugs.
The goal of Peptide CMC development is to ensure the consistency, stability and quality of peptide drugs to meet the requirements for clinical use. This requires a comprehensive consideration of the chemical properties of peptides, the feasibility of manufacturing processes and quality control to ensure the safety and efficacy of peptide drugs.
Longstanding CMC expertise
Decades of peptide leadership ensures deep scientific knowhow and best‑practice CMC strategies tailored to each molecule.
End‑to‑end development support
From early formulation and process development to clinical materials and commercial manufacturing – support every stage of the drug lifecycle.
cGMP manufacturing
Facilities are regularly inspected and approved by leading global authorities, ensuring consistent quality, safety, and regulatory compliance.
Innovative technologies
Advanced technologies, continuous innovation, and modern manufacturing solutions.